BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3981223)

  • 1. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.
    Loeffler JS; Ervin TJ; Mauch P; Skarin A; Weinstein HJ; Canellos G; Cassady JR
    J Clin Oncol; 1985 Apr; 3(4):490-4. PubMed ID: 3981223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma.
    Pollack IF; Lunsford LD; Flickinger JC; Dameshek HL
    Cancer; 1989 Mar; 63(5):939-47. PubMed ID: 2914300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary lymphoma of the central nervous system. An unresolved therapeutic problem.
    Socié G; Piprot-Chauffat C; Schlienger M; Legars D; Thurel C; Mikol J; Ifran N; Brière J; Pene F; Gindrey-Vie B
    Cancer; 1990 Jan; 65(2):322-6. PubMed ID: 2295054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol.
    Raz I; Siegal T; Siegal T; Polliack A
    Arch Neurol; 1984 Nov; 41(11):1167-71. PubMed ID: 6487100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central nervous system involvement in non-Hodgkin's lymphoma].
    Nishikori M; Sorachi K; Doi S; Arita Y; Kamesaki H; Ohno H; Kita K; Fukuhara S; Uchino H; Yamabe H
    Rinsho Ketsueki; 1986 Nov; 27(11):2051-8. PubMed ID: 3820624
    [No Abstract]   [Full Text] [Related]  

  • 7. Central nervous system involvement in non-Hodgkin's lymphoma.
    Liang RH; Woo EK; Yu YL; Todd D; Chan TK; Ho FC; Tso SC; Shum JS
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):703-10. PubMed ID: 2714346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
    Wu HG; Kim IH; Ha SW; Park CI; Bang YJ; Huh DS
    J Korean Med Sci; 1999 Oct; 14(5):565-70. PubMed ID: 10576154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical problems in the treatment of primary central nervous system malignant lymphoma].
    Keyaki A; Nabeshima S; Hashimoto S; Waga S
    No To Shinkei; 2000 Sep; 52(9):781-7. PubMed ID: 11064864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy in primary non-Hodgkin's lymphomas of the CNS.
    Rampen FH; van Andel JG; Sizoo W; van Unnik JA
    Eur J Cancer (1965); 1980 Feb; 16(2):177-84. PubMed ID: 7371676
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
    Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
    Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system involvement in non-Hodgkin's lymphoma.
    Chung MY; Chang YC; Chen RC
    Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):378-84. PubMed ID: 3598549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stereotaxic biopsy for primary lymphomas of the central nervous system].
    Meneses MS; O'Neill BP; Kelly PJ
    Arq Neuropsiquiatr; 1992 Sep; 50(3):319-23. PubMed ID: 1308409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A five-year experience with central nervous system lymphoma.
    Kotasek D; Albertyn LE; Sage RE
    Med J Aust; 1986 Mar; 144(6):299-303. PubMed ID: 3713621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients.
    Hoerni-Simon G; Suchaud JP; Eghbali H; Coindre JM; Hoerni B
    Oncology; 1987; 44(2):98-101. PubMed ID: 3574856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure.
    Michalski JM; Garcia DM; Kase E; Grigsby PW; Simpson JR
    Radiology; 1990 Sep; 176(3):855-60. PubMed ID: 2389047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.